VYGR:Voyager Therapeutics Inc Snapshot | Charting | News | Options
$7.63 NASDAQ 4:30p ET
April 22 '24 		Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy ... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
     GlobeNewswire
    Full Story →

    Headline News
    Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
    7:00a ET April 16 '24 GlobeNewswire
    Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    4:01p ET March 26 '24 GlobeNewswire
    Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
    7:00a ET March 13 '24 GlobeNewswire
    More News →
    Day  2.83%Week  1.73%Month  20.19%More Charting →
    Today, 12:52p ET Friday April 26 '24. Markets Open.
    Last $7.63
    Day change   2.83%$0.21
    Open $7.4
    Gap at open $0.02
    Previous close $7.42
    Trading volume 129,682
    10 Day avg vol. 521,970
    Shares out. 54.3Mil
    Market cap. $414.3Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 25 '24.

    Historical Price Performance
    3 month   1.60% 
    6 month   19.03% 
    1 year   4.81% 
    2 year   4.81% 

    Earnings
    Previous 12m $2.96
    Next 12m Estimate -$1.80
    P/E ratio 2.6x
    Revenue 250Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.